Research & Development



  衛青放下粥碗搖搖頭道︰“趁著我還沒死,她還是來這里的好,有些話當面跟陛下說清楚,遠比在長安自作主張的好。”   雲瑯淡淡的道︰“臣乃是大漢的衛將軍,幟飛虎旗,自然自喻為猛虎。微臣這頭猛虎不是不能茹素,而是擔心茹素時間長了,就忘記了該怎麼吃肉了。”chaopeng超碰公开视频   這一幕落在衛皇後眼中卻別有一份感慨。超碰最新上传视频97   甦稚笑道︰“我們隨陛下封禪完畢之後就要回去了,就不勞動母親千里奔波了。”   眼看著諸侯王們如同鍋底一般的臉色,曹襄頓時覺得自己通體舒泰。av人人视频超碰在线看   “大師兄不可能用拳頭去對付全天下的人,總有一天他會遇到拳頭比他大,比他硬的人,那時候,他說不定就會跟別人講道理了。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo